胃がん治療の発展を目指す

お知らせ

・  治療開発MAPが更新されました

・  JCOGのHPで患者市民参画が作成されました

・  JCOG胃がんグループHPを開設しました

・ Facebookを開設しました                            

・  Twitterを開設しました

論文掲載情報

2020.11

Gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer (JCOG0501): an open-label, phase 3, randomized controlled trial

2020.07

Randomized phase II/III study of 5-fluorouracil/l-leucovorin versus 5-fluorouracil/l-leucovorin plus paclitaxel administered to patients with severe peritoneal metastases of gastric cancer (JCOG1108/WJOG7312G)

2020.07

Randomized controlled Phase III trial to evaluate omentum preserving gastrectomy for patients with advanced gastric cancer (JCOG1711, ROAD-GC)

2020.06

Posttherapy topographical nodal status, ypN-site, predicts survival of patients who received neoadjuvant chemotherapy followed by curative surgical resection for non-type 4 locally advanced gastric cancer: supplementary analysis of JCOG1004-A

2020.06

Impact of postoperative complications on survival outcomes in patients with gastric cancer: exploratory analysis of a randomized controlled JCOG1001 trial

2020.05

Current Status of Perioperative Chemotherapy for Locally Advanced Gastric Cancer and JCOG Perspectives

2020.03

Diagnosis of Invasion Depth in Resectable Advanced Gastric Cancer for Neoadjuvant Chemotherapy: An Exploratory Analysis of Japan Clinical Oncology Group Study: JCOG1302A

A Phase II Study of Preoperative Chemotherapy With Docetaxel, Oxaliplatin and S-1 in Gastric Cancer With Extensive Lymph Node Metastasis (JCOG1704)　　

2020.02

Randomized Phase II/III Study of 5-fluorouracil/l-leucovorin Versus 5-fluorouracil/l-leucovorin Plus Paclitaxel Administered to Patients With Severe Peritoneal Metastases of Gastric Cancer (JCOG1108/WJOG7312G)